Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Postgraduate Medical Journal|December 1, 1993
Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugsI Rajman, M J KendallDrug Safety|March 1, 1994
A risk-benefit assessment of celiprolol in the treatment of cardiovascular diseaseM J Kendall, I RajmanVojnosanitetski Pregled|January 1, 1992
[Enanthema fixum as side effect in the use of a combination of trimethoprim and sulfamethoxazole]F Arifhodzić, I Rajman, S Petronijević, et al.QJM : Monthly Journal of the Association of Physicians|December 1, 1994
Particle size: the key to the atherogenic lipoprotein?I Rajman, S Maxwell, R Cramb, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 1998
Low-density lipoprotein subfraction profiles in chronic renal failureI Rajman, L Harper, D McPake, et al.Atherosclerosis|September 6, 1996
Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic menI Rajman, M J Kendall, R Cramb, et al.Journal of the American College of Cardiology|May 12, 2000
Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxationK L McNeill, L Fontana, D L Russell-Jones, et al.QJM : Monthly Journal of the Association of Physicians|October 1, 1996
Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapyI Rajman, G Y Lip, R Cramb, et al.Journal of Human Hypertension|April 9, 2010
Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndromeW Krone, M Hanefeld, H-F Meyer, et al.Clinical Pharmacology and Therapeutics|June 10, 2017
Evaluation of Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Sacubitril/Valsartan (LCZ696) and Sildenafil in Patients With Mild-to-Moderate HypertensionH-L Hsiao, T H Langenickel, J Petruck, et al.Pageof 1